EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Beneficial effects of automated insulin delivery over one‐year follow‐up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics

Zoé Henry, Sylvie Villar Fimbel, Nathalie Bendelac, Kevin Perge, Charles Thivolet iD

Diabetes, Obesity and Metabolism · 2024-02 · 26 (2) · 557-566

DOI: 10.1111/dom.15344 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 31.10.2023. Verfasst von Zoé Henry und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Diabetes DIAB-eCARE, Hospices Civils de Lyon, Lyon, France. Hauptthemen laut MEDLINE: Insulin, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To investigate glycaemic outcomes in youths and adults with type 1 diabetes with either MiniMed™ 780G or Tandem t:slim X2™ control‐IQ automated insulin delivery (AID) systems and to evaluate clinical factors that migrate, mitigate the achievement of therapeutic goals. Materials and Methods This retrospective, real‐world, observational study was conducted in a specialized university type 1 diabetes centre with patients observed for 3‐12 months post‐initiation of an AID system. Primary outcomes were the percentage time in the target glucose range [TIR 70‐180 mg/dl (3.9‐10 mmol/L)] as measured by continuous glucose monitoring, mean glucose management indicator (GMI) and glycated haemoglobin (HbA1c) levels.

Results

Our study cohort consisted of 48 adolescents and 183 adults (55% females) aged 10‐77 years. The mean (95% confidence interval) TIR 70‐180 mg/dl after 30 days was higher than baseline and by 14% points after 360 days with 71.33% (69.4‐73.2) (n = 123, p < .001). HbA1c levels decreased by 0.7% and GMI by 0.6% after 360 days. The proportion of time spent 70%, HbA1c levels or GMI

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinDiabetes Mellitus, Type 1AdultFemaleHumansAdolescentMaleHypoglycemic AgentsGlycated HemoglobinBlood Glucose Self-MonitoringRetrospective StudiesFollow-Up StudiesBlood GlucoseInsulin, Regular, HumanGlucoseInsulin Infusion Systems

Stichwörter der Autor:innen

automated insulin deliveryclosed-loop systemdiabetesreal-world evidencetime in range

Substanzen

InsulinHypoglycemic AgentsGlycated HemoglobinBlood GlucoseInsulin, Regular, HumanGlucose

Autor:innen und Institutionen

  • Centre for Diabetes DIAB-eCARE, Hospices Civils de Lyon, Lyon, France.
  • Department of paediatric Endocrinology and Diabetes, Hospices Civils de Lyon, Bron, France.

ORCID-Profile: Charles Thivolet

Zitieren

APA

Henry, Z., Villar Fimbel, S., Bendelac, N., Perge, K., & Thivolet, C. (2024). Beneficial effects of automated insulin delivery over one‐year follow‐up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics. Diabetes, Obesity and Metabolism, 26(2), 557-566. https://doi.org/10.1111/dom.15344

Vancouver

Henry Z, Villar Fimbel S, Bendelac N, Perge K, Thivolet C. Beneficial effects of automated insulin delivery over one‐year follow‐up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics. Diabetes, Obesity and Metabolism. 2024;26(2):557-566. doi:10.1111/dom.15344

BibTeX
@article{Henry2024,
  author = {Henry, Zoé and Villar Fimbel, Sylvie and Bendelac, Nathalie and Perge, Kevin and Thivolet, Charles},
  title = {Beneficial effects of automated insulin delivery over one‐year follow‐up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  volume = {26},
  number = {2},
  pages = {557--566},
  doi = {10.1111/dom.15344}
}
Kostenlos starten →